Drugs / L. reuteri Prodentis®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02789436 | Jun → Sep 2016 | — | University of Zagreb | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L. reuteri Prodentis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02789436 ↗ |
| Known as | Prodentis | “The purpose of this study is to determine whether Lactobacillus reuteri-containing lozenges (Prodentis) are effective in treatment of halitosis in patients with chronic periodontitis.” NCT02789436 ↗ |